The landscape of diabetes care is evolving with the emergence of transdermal GLP-1 delivery . These novel patches offer a possibly more comfortable alternative to injections for individuals dealing with type 2 diabetes . These patches deliver a GLP-1 agonist directly through the dermis , avoiding